View monthly record counts
| Month | Records |
|---|---|
| 2 |
Data updated:
| Month | Records |
|---|---|
| 2 |
| # | Country / Region | Records |
|---|---|---|
| 1 | India | 2 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300390 | 未列名两种或两种以上成分混合而成的药品,未配定剂量或制成零售包装 | Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excluding antibiotics containing hormones or steroids used as hormones, but not containing antibiotics, alkaloids or derivatives thereof, hormones or antibiotics or goods of heading 3002, 3005 or 3006) | 2 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | CIPLA LIMITED | INDIA | 2 |
| Date | Jan 24, 2023 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | CRYSTEC PHARMA | Buyer Information | Company Name | CIPLA LIMITED |
| Address | — | Address | — | ||
| Registration No. | — | Registration No. | 0388003791 | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30039090 | HS Description | 未列名两种或两种以上成分混合而成的药品,未配定剂量或制成零售包装Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excluding antibiotics containing hormones or steroids used as hormones, but not containing antibiotics, alkaloids or derivatives thereof, hormones or antibiotics or goods of heading 3002, 3005 or 3006) | |
| Product Description | (N.C.V.) FLUTICASONE PROPIONATE (5 GMS) (FOR TESTING PURPOSE ONLY) | Brand | — | ||
| Quantity & Price | Amount | 1.25 | Weight | — | |
| Quantity | 1 NOS | TEU | — | ||
| Shipment Information | Origin Country | UNITED KINGDOM | Destination Country | INDIA | |
| Port of Loading | — | Destination Port | — | ||
| Loading Place | — | Transport Mode | UNKNOWN | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||